Ultra Market Research | Over the Counter (OTC) Drugs Market
Over the Counter (OTC) Drugs Market
Report ID : 619
Category : Pharmaceuticals
No Of Pages : 130
Published on: August 2024
Status: Published
Format :
Key Question Answer
Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
Over the Counter (OTC) Drugs Market Over-the-counter (OTC) medication industry was estimated to be worth US$ XX billion in 2023 and is projected to increase at a compound annual growth rate (CAGR) of XX% from 2024 to 2033, reaching around US$ XX billion by that time. The market for over-the-counter (OTC) medications has grown due to their availability and guarantee of safety and effectiveness when taken as prescribed. OTC medications, sometimes referred to as nonprescription medications, give customers easy access to treatment for common illnesses without the need for a prescription. When patients follow the directions on the container and consult a doctor when necessary, these drugs are regarded as safe and effective. The market for over-the-counter medications has been growing due in large part to rising customer confidence in their ability to manage minor health conditions on their own and greater emphasis on self-care.
Market Overview Ease of use and availability of over-the-counter (OTC) drugs—which can be purchased without a prescription—are fueling the market's explosive expansion. Many conditions and symptoms, such as pain, colds and coughs, diarrhea, constipation, acne, heartburn, and fungal infections, are treated by over-the-counter medications. When the instructions on the "Drug Facts Label" are adhered to, these drugs are considered safe and effective for general use. OTC medications are widely available due to the shift from prescription to over-the-counter (Rx-to-OTC) use, which can be found on shelves at pharmacies, grocery stores, petrol stations, and online. Proton-pump inhibitors such as esomeprazole (Nexium 24HR) and heartburn drugs like famotidine (Pepcid AC) are notable examples. Products like the nasal spray Nasonex 24HR Allergy and multiple 2023 approvals (Narcan and RiVive naloxone nasal sprays for opioid overdose) as well as the oral birth control pill Opill, which solely contains progestin, have recently moved from prescription to over-the-counter status. This change highlights the growing trend towards self-managed healthcare solutions and improves consumer access to necessary treatments and spurs market expansion. . Key Insights
• The North America over the counter (OTC) drugs market. • By route of administration, the oral segment has accounted largest market share. • The parenteral segment has captured largest market share.
Regional Stance Global over-the-counter (OTC) medicine market is dominated by the North American region, especially the US. For the treatment and prevention of many common illnesses, including musculoskeletal pain, headaches, colds, allergies, heartburn, dermatitis, obesity, tobacco habit, and dental caries, Americans are depending more and more on over-the-counter (OTC) medications. This paper explores the vital role that over-the-counter (OTC) medications play in the American healthcare system, providing information on pharmaceutical usage, clinical and consumer research findings, and professional treatment standards. OTC drugs—which are available without a prescription—play a critical role in preserving Americans' health, highlighting their place in the country's healthcare system and fueling the OTC market's rapid expansion in the area. Throughout the projection period, Europe is expected to be the most lucrative region in the worldwide over-the-counter (OTC) medicine market. It is difficult to establish a standard procedure for moving prescription drugs from prescription-only to over-the-counter (OTC) status throughout Europe because of previous national reviews, disparate reimbursement schemes, and cultural variations. While most pharmaceuticals in EU member states are still categorized as prescription-only (POM), others are becoming over-the-counter (OTC). 48 over-the-counter (OTC) medications, mostly intended for topical application for brief treatments, were found to contain 20 distinct single antibiotics and three antibiotic combos according to a European survey. This move toward over-the-counter (OTC) availability, particularly for systemic and topical antibiotics, suggests substantial market potential and expansion prospects in the European region.
Report Highlights By Product Within the market for over-the-counter (OTC) medications, cough and cold remedies have the most market share. It is important to have a basic grasp of the active components in over-the-counter (OTC) medications for cold, flu, and allergy symptoms because consumers are sometimes faced with a bewildering assortment of options. Decongestants are the first line of treatment for a stuffy, clogged nose because they reduce blood flow and fluid leakage in nasal tissues by constricting blood vessels. These can be applied topically as nasal sprays or drops, orally as well. Expectorants, which aid in clearing mucus, and cough suppressants, which lessen the urge to cough, are the two categories of cough medications. This extensive selection of cough and cold medications guarantees efficient symptom management and highlights the category's notable market dominance. Over the course of the projection period, analgesics are expected to see substantial growth in the over-the-counter (OTC) medicine market. When used as prescribed, the four OTC oral analgesics (acetaminophen, aspirin, ibuprofen, and naproxen) provide safe, efficient, and affordable relief for mild to moderate pain, inflammation, and fever in the United States. These drugs are frequently involved in overdose cases, which can be attributed to their perceived safety and accessibility. Analgesics are a basic tool for treating common pain and discomfort; in Western nations, as much as 70% of people frequently use them for headaches, particular types of pain, and fever-related ailments. This high usage highlights the considerable market potential and anticipated strong expansion of the analgesics category.
By Distribution Channel With the largest market share, the over-the-counter (OTC) medicine industry is led by the drug shops and retail pharmacies segment. These methods of distribution play a critical role in giving customers immediate access to over-the-counter (OTC) medications, which efficiently cure a variety of ailments and symptoms like pain, colds, coughs, diarrhea, constipation, and acne. Drug stores and retail pharmacies dominate the market because of their accessibility and ease, which allows customers to easily get necessary over-the-counter medications without a prescription. Drug stores and retail pharmacies are essential to the ongoing development and market penetration of over-the-counter (OTC) medications due to their accessibility and extensive availability. The over-the-counter (OTC) medicine market's fastest-growing distribution channel is the online pharmacy sector. Online pharmacies have been much more common during the last three to five years, especially in the Indian subcontinent. This "E-pharmacy" industry expansion has been carefully examined and recorded. Online pharmacies give clients the convenience of fast home delivery of their orders using a web-based platform that allows them to buy prescription medications and related services online. This quick increase demonstrates the growing inclination of consumers toward digital solutions as well as the possibility for significant market expansion in the online pharmacy space.
Market Dynamics Driver Growing Trend and Regulatory Focus OTC medications have seen a steady growth in use in recent years due to a number of variables including easy availability, cost, and greater patient knowledge. Medications that can be obtained over-the-counter, or OTC medicines, are also referred to as nonprescription medicines. Several nations have recognized over-the-counter (OTC) medications as a separate class and have implemented rules to guarantee their safe usage. The market has grown tremendously because it is permitted for pharmacists to sell these drugs without a prescription. The dual nature of over-the-counter medications needs strict regulation for their distribution, sale, and classification. While they may be convenient, there is also a chance of misuse and safety issues. The market for over-the-counter medications is growing as a result of this governmental emphasis along with customer demand.
Restraints Health Risks and Misuse Over-the-counter (OTC) pain reliever usage and misuse are serious barriers to the market's expansion. Long-term abuse can cause psychological symptoms like depression, cognitive impairments including memory and learning problems, and organ damage like liver and kidney problems. Contrary to the pursuit of euphoric effects, misuse frequently results from attempts to treat chronic pain or everyday aches, which exacerbates consumer safety concerns and regulatory monitoring. To lessen the impact on the market for over-the-counter medications' potential for growth, it is imperative to address these health hazards through increased surveillance and education.
Opportunities High Consumption and Health Trends Over-the-counter (OTC) drug use is on the rise, with certain groups using OTC drugs more frequently than prescription drugs. This represents a potential area for market expansion. OTC drug use is more prevalent, especially among groups with non-formal or university-level education. OTC medications may fill some of the gaps left by recent increases in pharmaceutical use, as overall health outcomes have not improved in line with these increases. Possibility for over-the-counter drugs to improve public health and address unmet healthcare requirements, which will encourage additional market growth
Recent Developments
• In June 2022, the FTC initiated an inquiry into the prescription drug middlemen industry • In April 2024, a panel finalized a list of over-the-counter drugs for sale at general stores • In March 2024, Perrigo commenced shipments of Opill to retailers nationwide, expanding access to reproductive health in the United States • In June 2024, concerns were raised over competition following the proposed merger between Sigma and Chemist Warehouse
Key Players in the Over the Counter (OTC) Drugs Market Bayer AG Takeda Pharmaceutical Company Ltd. Pfizer Johnson & Johnson Services Inc. Sanofi S.A. Reckitt Benckiser Group PLC Novartis AG Boehringer Ingelheim International GmbH GlaxoSmithKline PLC Mylan
Market Segmentation
By Product Type Vitamin and Dietary Supplements Cough & Cold Products Analgesics Gastrointestinal Products Sleep Aids Otic Products Wart Removers Mouth Care Products Ophthalmic Products Botanicals Antacids Smoking Cessation Products Feminine Care Others
By Dosage Form Tablets Hard Capsules Powders Ointments Soft Capsules Liquids Others
By Route of Administration Oral Parenteral Topical Others
By Distribution Channel Drug Stores & Retail Pharmacies Hospital Pharmacies Online Pharmacies
By Geography North America U.S. Canada Europe Germany France United Kingdom Rest of Europe Asia Pacific China Japan India Southeast Asia Rest of Asia Pacific Latin America Brazil Rest of Latin America Middle East & Africa (MEA) GCC North Africa South Africa Rest of Middle East & Africa
Table of content 1. Introduction 1.1. Report Description 1.2. Research Methodology 1.2.1. Data Mining 1.2.2. Market Modeling and Forecasting 1.2.3. Data Validation 1.2.4. Industry Analysis
4. Over the Counter (OTC) Drugs Market by Product Type 4.1. Introduction 4.2. Over the Counter (OTC) Drugs Market Size and Growth Rate by Product Type (2021-2030) 4.3. Vitamin and Dietary Supplements 4.3.1. Vitamin and Dietary Supplements Market Size and Growth Rate (2022 - 2030) 4.4. Gastrointestinal Products 4.4.1. Gastrointestinal Products Market Size and Growth Rate (2022 - 2030) 4.5. Analgesics 4.5.1. Analgesics Market Size and Growth Rate (2021-2030) 4.6. Sleep Aids 4.6.1. Sleep Aids Market Size and Growth Rate (2021-2030) 4.7. Otic Products 4.7.1. Otic Products Market Size and Growth Rate (2021-2030) 4.8. Wart Removers 4.8.1. Wart Removers Market Size and Growth Rate (2021-2030) 4.9. Mouth Care Products 4.9.1. Mouth Care Products Market Size and Growth Rate (2021-2030) 4.10. Ophthalmic Products 4.10.1. Ophthalmic Products Market Size and Growth Rate (2021-2030) 4.11. Botanicals 4.11.1. Botanicals Market Size and Growth Rate (2021-2030) 4.12. Antacids 4.12.1. Antacids Market Size and Growth Rate (2021-2030) 4.13. Smoking Cessation Products 4.13.1. Smoking Cessation Products Market Size and Growth Rate (2021-2030) 4.14. Feminine Care 4.14.1. Feminine Care Market Size and Growth Rate (2021-2030) 4.15. Others 4.15.1. Others Market Size and Growth Rate (2021-2030)
5. Over the Counter (OTC) Drugs Market by Dosage Form 5.1. Introduction 5.2. Over the Counter (OTC) Drugs Market Size and Growth Rate by Dosage Form (2021-2030) 5.3. Tablets 5.3.1. Tablets Market Size and Growth Rate (2021-2030) 5.4. Hard Capsules 5.4.1. Hard Capsules Market Size and Growth Rate (2021-2030) 5.5. Powders 5.5.1. Powders Market Size and Growth Rate (2021-2030) 5.6. Ointments 5.6.1. Ointments Market Size and Growth Rate (2021-2030) 5.7. Soft Capsules 5.7.1. Soft Capsules Market Size and Growth Rate (2021-2030) 5.8. Liquids 5.8.1. Liquids Market Size and Growth Rate (2021-2030) 5.9. Others 5.9.1. Others Market Size and Growth Rate (2021-2030)
6. Over the Counter (OTC) Drugs Market by Route of Administration 6.1. Introduction 6.2. Over the Counter (OTC) Drugs Market Size and Growth Rate by Route of Administration (2021-2030) 6.3. Oral 6.3.1. Oral Market Size and Growth Rate (2021-2030) 6.4. Parenteral 6.4.1. Parenteral Market Size and Growth Rate (2021-2030) 6.5. Topical 6.5.1. Topical Market Size and Growth Rate (2021-2030) 6.6. Others 6.6.1. Others Market Size and Growth Rate (2021-2030)
7. Over the Counter (OTC) Drugs Market by Distribution Channel 7.1. Introduction 7.2. Over the Counter (OTC) Drugs Market Size and Growth Rate by Distribution Channel (2021-2030) 7.3. Drug Stores & Retail Pharmacy 7.3.1. Drug Stores & Retail Pharmacy Market Size and Growth Rate (2021-2030) 7.4. Hospital Pharmacies 7.4.1. Hospital Pharmacies Market Size and Growth Rate (2021-2030) 7.5. Online Pharmacies 7.5.1. Online Pharmacies Market Size and Growth Rate (2021-2030)
8. Company Profiles 8.1. Bayer AG 8.1.1. Business Overview 8.1.2. Product Portfolio 8.1.3. Strategic Developments 8.1.4. Financial Overview
8.2. Takeda Pharmaceutical Company Ltd. 8.2.1. Business Overview 8.2.2. Product Portfolio 8.2.3. Strategic Developments 8.2.4. Financial Overview
9. List of Tables and Figures Table Over the Counter (OTC) Drugs Market Size and Market Share by Product Type (2021-2023) Table Over the Counter (OTC) Drugs Market Size and Market Share by Product Type (2023-2030) Figure Vitamin and Dietary Supplements Market Size and Growth Rate (2021-2030) Figure Cough & Cold Products Market Size and Growth Rate (2021-2030) Figure Analgesics Market Size and Growth Rate (2021-2030) Figure Gastrointestinal Products Market Size and Growth Rate (2021-2030) Figure Sleep Aids Market Size and Growth Rate (2021-2030) Figure Otic Products Market Size and Growth Rate (2021-2030) Figure Wart Removers Market Size and Growth Rate (2021-2030) Figure Mouth Care Products Market Size and Growth Rate (2021-2030) Figure Ophthalmic Products Market Size and Growth Rate (2021-2030) Figure Botanicals Market Size and Growth Rate (2021-2030) Figure Antacids Market Size and Growth Rate (2021-2030) Figure Smoking Cessation Products Market Size and Growth Rate (2021-2030) Figure Feminine Care Market Size and Growth Rate (2021-2030) Figure Others Market Size and Growth Rate (2021-2030)
Table Over the Counter (OTC) Drugs Market Size and Market Share by Dosage Form (2021-2023) Table Over the Counter (OTC) Drugs Market Size and Market Share by Dosage Form (2023-2030) Figure Tablets Market Size and Growth Rate (2021-2030) Figure Hard Capsules Market Size and Growth Rate (2021-2030) Figure Powders Market Size and Growth Rate (2021-2030) Figure Ointments Market Size and Growth Rate (2021-2030) Figure Soft Capsules Market Size and Growth Rate (2021-2030) Figure Liquids Market Size and Growth Rate (2021-2030) Figure Others Market Size and Growth Rate (2021-2030)
Table Over the Counter (OTC) Drugs Market Size and Market Share by Route of Administration (2021-2023) Table Over the Counter (OTC) Drugs Market Size and Market Share by Route of Administration (2023-2030) Figure Oral Market Size and Growth Rate (2021-2030) Figure Parenteral Market Size and Growth Rate (2021-2030) Figure Topical Market Size and Growth Rate (2021-2030) Figure Others Market Size and Growth Rate (2021-2030)
Table Over the Counter (OTC) Drugs Market Size and Market Share by Distribution Channel (2021-2023) Table Over the Counter (OTC) Drugs Market Size and Market Share by Distribution Channel (2023-2030) Figure Drug Stores & Retail Pharmacy Market Size and Growth Rate (2021-2030) Figure Hospital Pharmacies Market Size and Growth Rate (2021-2030) Figure Online Pharmacies Market Size and Growth Rate (2021-2030)
Table Over the Counter (OTC) Drugs Market by Regions (2021-2023) Table Over the Counter (OTC) Drugs Market by Regions (2023-2030) Figure North America Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table North America Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table North America Over the Counter (OTC) Drugs Market by Product Type (2023-2030) Table North America Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table North America Over the Counter (OTC) Drugs by Dosage Form (2023-2030) Table North America Over the Counter (OTC) Drugs by Route of Administration (2021-2023) Table North America Over the Counter (OTC) Drugs by Route of Administration (2023-2030) Figure United States Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table United States Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table United States Over the Counter (OTC) Drugs Market by Product Type (2023-2030) Table United States Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table United States Over the Counter (OTC) Drugs by Dosage Form (2023-2030) Figure Canada Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table Canada Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table Canada Over the Counter (OTC) Drugs Market by Product Type (2023-2030) Table Canada Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table Canada Over the Counter (OTC) Drugs by Dosage Form (2023-2030) Figure Europe Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table Europe Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table Europe Over the Counter (OTC) Drugs Market by Product Type (2023-2030) Table Europe Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table Europe Over the Counter (OTC) Drugs by Dosage Form (2023-2030) Table Europe Over the Counter (OTC) Drugs by Route of Administration (2021-2023) Table Europe Over the Counter (OTC) Drugs by Route of Administration (2023-2030) Figure Germany Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table Germany Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table Germany Over the Counter (OTC) Drugs Market by Product Type (2023-2030) Table Germany Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table Germany Over the Counter (OTC) Drugs by Dosage Form (2023-2030) Figure France Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table France Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table France Over the Counter (OTC) Drugs Market by Product Type (2023-2030) Table France Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table France Over the Counter (OTC) Drugs by Dosage Form (2023-2030) Figure UK Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table UK Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table UK Over the Counter (OTC) Drugs Market by Product Type (2023-2030) Table UK Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table UK Over the Counter (OTC) Drugs by Dosage Form (2023-2030) Figure Russia Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table Russia Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table Russia Over the Counter (OTC) Drugs Market by Product Type (2023-2030) Table Russia Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table Russia Over the Counter (OTC) Drugs by Dosage Form (2023-2030) Figure Italy Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table Italy Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table Italy Over the Counter (OTC) Drugs Market by Product Type (2023-2030) Table Italy Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table Italy Over the Counter (OTC) Drugs by Dosage Form (2023-2030) Figure Rest of Europe Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table Rest of Europe Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table Rest of Europe Over the Counter (OTC) Drugs Market by Product Type (2023-2030) Table Rest of Europe Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table Rest of Europe Over the Counter (OTC) Drugs by Dosage Form (2023-2030) Figure Asia-Pacific Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table Asia-Pacific Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table Asia-Pacific Over the Counter (OTC) Drugs Market by Product Type (2023-2030) Table Asia-Pacific Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table Asia-Pacific Over the Counter (OTC) Drugs by Dosage Form (2023-2030) Table Asia-Pacific Over the Counter (OTC) Drugs by Route of Administration (2021-2023) Table Asia-Pacific Over the Counter (OTC) Drugs by Route of Administration (2023-2030) Figure China Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table China Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table China Over the Counter (OTC) Drugs Market by Product Type (2023-2030) Table China Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table China Over the Counter (OTC) Drugs by Dosage Form (2023-2030) Figure Japan Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table Japan Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table Japan Over the Counter (OTC) Drugs Market by Product Type (2023-2030) Table Japan Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table Japan Over the Counter (OTC) Drugs by Dosage Form (2023-2030) Figure Korea Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table Korea Over the Counter (OTC) Drugs Market by ProductType (2021-2023) Table Korea Over the Counter (OTC) Drugs Market by Product Type (2023-2030) Table Korea Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table Korea Over the Counter (OTC) Drugs by Dosage Form (2023-2030) Figure India Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table India Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table India Over the Counter (OTC) Drugs Market by Product Type (2023-2030) Table India Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table India Over the Counter (OTC) Drugs by Dosage Form (2023-2030) Figure Southeast Asia Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table Southeast Asia Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table Southeast Asia Over the Counter (OTC) Drugs Market by Product Type (2023-2030) Table Southeast Asia Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table Southeast Asia Over the Counter (OTC) Drugs by Dosage Form (2023-2030) Figure Rest of Asia-Pacific Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table Rest of Asia-Pacific Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table Rest of Asia-Pacific Over the Counter (OTC) Drugs Market by ProductType (2023-2030) Table Rest of Asia-Pacific Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table Rest of Asia-Pacific Over the Counter (OTC) Drugs by Dosage Form (2023-2030) Figure South America Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table South America Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table South America Over the Counter (OTC) Drugs Market by ProductType (2023-2030) Table South America Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table South America Over the Counter (OTC) Drugs by Dosage Form (2023-2030) Table South America Over the Counter (OTC) Drugs by Route of Administration (2021-2023) Table South America Over the Counter (OTC) Drugs by Route of Administration (2023-2030) Figure Brazil Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table Brazil Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table Brazil Over the Counter (OTC) Drugs Market by Product Type (2023-2030) Table Brazil Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table Brazil Over the Counter (OTC) Drugs by Dosage Form (2023-2030) Figure Mexico Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table Mexico Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table Mexico Over the Counter (OTC) Drugs Market by Product Type (2023-2030) Table Mexico Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table Mexico Over the Counter (OTC) Drugs by Dosage Form (2023-2030) Figure Columbia Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table Columbia Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table Columbia Over the Counter (OTC) Drugs Market by Product Type (2023-2030) Table Columbia Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table Columbia Over the Counter (OTC) Drugs by Dosage Form (2023-2030) Figure Rest of South America Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table Rest of South America Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table Rest of South America Over the Counter (OTC) Drugs Market by Product Type (2023-2030) Table Rest of South America Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table Rest of South America Over the Counter (OTC) Drugs by Dosage Form (2023-2030) Figure Middle East and Africa Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table Middle East and Africa Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table Middle East and Africa Over the Counter (OTC) Drugs Market by Product Type (2023-2030) Table Middle East and Africa Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table Middle East and Africa Over the Counter (OTC) Drugs by Route of Administration (2021-2023) Table Middle East and Africa Over the Counter (OTC) Drugs by Route of Administration (2023-2030) Figure Saudi Arabia Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table Saudi Arabia Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table Saudi Arabia Over the Counter (OTC) Drugs Market by Product Type (2023-2030) Table Saudi Arabia Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table Saudi Arabia Over the Counter (OTC) Drugs by Dosage Form (2023-2030) Figure United Arab Emirates Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table United Arab Emirates Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table United Arab Emirates Over the Counter (OTC) Drugs Market by Product Type (2023-2030) Table United Arab Emirates Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table United Arab Emirates Over the Counter (OTC) Drugs by Dosage Form (2023-2030) Figure South Africa Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table South Africa Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table South Africa Over the Counter (OTC) Drugs Market by Product Type (2023-2030) Table South Africa Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table South Africa Over the Counter (OTC) Drugs by Dosage Form (2023-2030) Figure Rest of Middle East and Africa Over the Counter (OTC) Drugs Market Size and Growth Rate (2021-2030) Table Rest of Middle East and Africa Over the Counter (OTC) Drugs Market by Product Type (2021-2023) Table Rest of Middle East and Africa Over the Counter (OTC) Drugs Market by Product Type (2023-2030) Table Rest of Middle East and Africa Over the Counter (OTC) Drugs by Dosage Form (2021-2023) Table Rest of Middle East and Africa Over the Counter (OTC) Drugs by Dosage Form (2023-2030)
Table Olympus Corporation Over the Counter (OTC) Drugs Financial Overview Table Bayer AG Over the Counter (OTC) Drugs Financial Overview Table Takeda Pharmaceutical Company Ltd. Over the Counter (OTC) Drugs Financial Overview Table Pfizer Over the Counter (OTC) Drugs Financial Overview Table Johnson & Johnson (Ethicon) Over the Counter (OTC) Drugs Financial Overview Table Sanofi S.A. Over the Counter (OTC) Drugs Financial Overview Table Reckitt Benckiser Group PLC Over the Counter (OTC) Drugs Financial Overview Table Novartis AG Over the Counter (OTC) Drugs Financial Overview Table Boehringer Ingelheim International GmbH Over the Counter (OTC) Drugs Financial Overview Table GlaxoSmithKline PLC Over the Counter (OTC) Drugs Financial Overview Table Mylan Over the Counter (OTC) Drugs Financial Overview
Research Methodology
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of Global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of Over the Counter (OTC) Drugs and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of Over the Counter (OTC) Drugs Market for the past year and forecasts for the next six years. Over the Counter (OTC) Drugs Market size is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of different Over the Counter (OTC) Drugs Market categories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand for Biopharmaceutical CMO and CRO Over the Counter (OTC) Drugs from different application industries in different regions.
Market Segmentation By Product Type Vitamin and Dietary Supplements Cough & Cold Products Analgesics Gastrointestinal Products Sleep Aids Otic Products Wart Removers Mouth Care Products Ophthalmic Products Botanicals Antacids Smoking Cessation Products Feminine Care Others By Dosage Form Tablets Hard Capsules Powders Ointments Soft Capsules Liquids Others By Route of Administration Oral Parenteral Topical Others By Distribution Channel Drug Stores & Retail Pharmacies Hospital Pharmacies Online Pharmacies
By Geography North America U.S. Canada Europe Germany France United Kingdom Rest of Europe Asia Pacific China Japan India Southeast Asia Rest of Asia Pacific Latin America Brazil Rest of Latin America Middle East & Africa (MEA) GCC North Africa South Africa Rest of Middle East & Africa
